세포은행 아웃소싱 세계 시장 규모는 2023년 133억 달러로 평가되었습니다. 2024년 155억 9,000만 달러에서 2032년에는 554억 9,000만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032) 동안 17.2%의 연평균 복합 성장률(CAGR)을 보일 전망입니다.
세계 세포은행 아웃소싱 시장은 냉동보존 및 세포은행 준비 기술의 발전에 힘입어 큰 폭의 성장이 예상됩니다. 단클론 항체 및 효과적인 바이오 의약품에 대한 수요 증가와 함께 줄기세포 치료의 보급이 이 분야를 더욱 촉진하고 있으며, 2020년 초에는 첨단 세포 치료 임상시험이 전 세계적으로 30% 증가하여 세포 은행 서비스에 대한 수요가 증가하고 있다는 주목할 만한 수치가 발표되어 세포 은행 서비스에 대한 수요를 뒷받침하고 있습니다. 정부 지원책과 세포주 보존 및 특성 분석의 혁신적 기술이 시장 확대에 박차를 가하고 있으며, Opsis Therapeutics와 FUJIFILM Cellular Dynamics와 같은 주요 업계 기업들 간의 공동연구가 R&D 노력을 촉진하고 있습니다. 인간 유도만능줄기세포의 효능을 입증하는 연구를 예로 들 수 있습니다.
Global Cell Banking Outsourcing Market size was valued at USD 13.3 billion in 2023 and is poised to grow from USD 15.59 billion in 2024 to USD 55.49 billion by 2032, growing at a CAGR of 17.2% during the forecast period (2025-2032).
The global cell banking outsourcing market is poised for substantial growth, fueled by advancements in cryopreservation and cell bank preparation techniques. The increasing prevalence of stem cell therapies, alongside a rising demand for monoclonal antibodies and effective biopharmaceuticals, is further propelling this sector. A notable 30% surge in global enrollments for advanced cell therapy trials in early 2020 underscores the escalating need for cell banking services. Supportive government initiatives and innovative technologies for cell line storage and characterization add momentum to market expansion. Collaborations among key industry players, such as Opsis Therapeutics and FUJIFILM Cellular Dynamics, bolster research and development efforts, exemplified by studies indicating the efficacy of human-induced pluripotent stem cells in enhancing health outcomes.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Banking Outsourcing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Banking Outsourcing Market Segments Analysis
Global Cell Banking Outsourcing Market is segmented by Type, Product, Cell Type, Phase and region. Based on Type, the market is segmented into Master Cell Banking, Viral Cell Banking and Working Cell Banking. Based on Product, the market is segmented into Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking and Embryonic Stem Cell Banking. Based on Cell Type, the market is segmented into Stem Cell and Non-Stem Cell. Based on Phase, the market is segmented into Bank Storage, Cell Storage Stability Testing, Bank Preparation and Bank Characterization and Testing. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cell Banking Outsourcing Market
A key factor propelling the global cell banking outsourcing market is the rising adoption of stem cell therapies, which is a burgeoning area within regenerative medicine known for its potential to address a variety of medical conditions. As the appetite for such therapies intensifies, the requirement for stable, high-quality cell lines becomes more pronounced, thereby boosting the demand for specialized cell banking services. Consequently, biopharmaceutical companies and contract research organizations (CROs) are increasingly turning to outsourcing for effective and economical solutions related to the production and preservation of these essential cell lines, ultimately driving market growth in this sector.
Restraints in the Global Cell Banking Outsourcing Market
A significant constraint on the global cell banking outsourcing market is the elevated cost associated with cell banking services. The cell banking process entails thorough testing and characterization to guarantee the quality and safety of cell lines, necessitating substantial investments in specialized equipment and infrastructure, which contributes to heightened service costs. Additionally, strict regulations enforced by regulatory authorities regarding the production and storage of cell lines further exacerbate expenses. Consequently, the high costs of these services may hinder their adoption, particularly in developing regions where healthcare budgets are constrained, creating a barrier to accessing essential cell banking solutions.
Market Trends of the Global Cell Banking Outsourcing Market
The Global Cell Banking Outsourcing market is currently witnessing a significant trend driven by the rising demand for personalized medicine which necessitates the use of genetically tailored cells for effective treatments. As healthcare evolves towards individualized approaches, cell banking firms are increasingly investing in advanced technologies and innovations to produce and store these specific cell types. This trend not only enhances treatment efficacy by aligning therapies with patients' unique genetic profiles but also propels market growth as more healthcare providers seek outsourcing solutions to streamline operations and improve patient outcomes. Consequently, the intersection of personalized medicine and cell banking is poised to reshape market dynamics.